DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype.
New Insights into Melanoma Tumor Syndromes.
Resilience of melanoma diagnostics at a tertiary-care hospital during the SARS-CoV-2 pandemic.
Melanoma classification and management in the era of molecular medicine.
Dermatol Clin. 2022;41(1):49-63 - PMID: 36410983 - DOI: 10.1016/j.det.2022.07.017
Divergent BRAF Inhibitor Resistance Mechanisms Revealed through Epigenetic Mapping.
J Invest Dermatol. 2022;143(5):842-853.e6 - PMID: 36529262 - DOI: 10.1016/j.jid.2022.03.039
5

